Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?
作者信息
Semsarian Caitlin R, Ma Tara, Nickel Brooke, Scolyer Richard A, Ferguson Peter M, Soyer H Peter, Parker Lisa, Barratt Alexandra, Thompson John F, Bell Katy J L
机构信息
Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
出版信息
Br J Dermatol. 2022 Jun;186(6):1030-1032. doi: 10.1111/bjd.21010. Epub 2022 Apr 7.
Abstract
摘要
相似文献
1
Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?我们是否需要重新思考原位黑素瘤和重度发育异常痣的诊断？
Br J Dermatol. 2022 Jun;186(6):1030-1032. doi: 10.1111/bjd.21010. Epub 2022 Apr 7.
2
Dysplastic melanocytic naevus syndrome.发育异常性黑素细胞痣综合征
Aust Fam Physician. 2006 Aug;35(8):601-2.
3
Dysplastic nevus syndrome.发育异常痣综合征
Arch Dermatol. 1987 Oct;123(10):1280.
4
Differentiating dysplastic nevi from melanoma.发育异常痣与黑色素瘤的鉴别。
JAMA. 1997 Aug 20;278(7):548-9. doi: 10.1001/jama.1997.03550070040030.
5
[Dysplastic melanocytic nevus].[发育异常性黑素细胞痣]
Duodecim. 2010;126(21):2492-501.
6
Diagnosis and management of dysplastic nevus syndrome and early melanoma.发育异常痣综合征及早期黑色素瘤的诊断与管理
Oncology (Williston Park). 1990 Jan;4(1):73-81; discussion 82-3.
7
Dysplastic naevi.发育异常痣
Histopathology. 1989 Jul;15(1):103-8. doi: 10.1111/j.1365-2559.1989.tb03052.x.
8
Dysplastic nevus: why this term should be abandoned in dermatoscopy.发育不良性痣：为何该术语在皮肤科皮镜检查中应被摒弃。
Dermatol Clin. 2013 Oct;31(4):579-88, viii. doi: 10.1016/j.det.2013.06.009. Epub 2013 Jul 23.
9
Dysplastic naevi: an update.发育不良痣：更新。
Histopathology. 2010 Jan;56(1):112-20. doi: 10.1111/j.1365-2559.2009.03450.x.
10
[Diagnosis of dysplastic nevus].[发育异常痣的诊断]
Dtsch Med Wochenschr. 1990 Jul 13;115(28-29):1104-7. doi: 10.1055/s-2008-1065128.
引用本文的文献
1
Local Recurrence and Survival in Patients With Melanoma In Situ.原位黑色素瘤患者的局部复发与生存情况
JAMA Dermatol. 2025 Sep 3. doi: 10.1001/jamadermatol.2025.3078.
2
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study.原位黑色素瘤替代诊断标签对管理选择和心理结果的影响：一项在线随机研究方案
BMJ Open. 2024 Dec 20;14(12):e089558. doi: 10.1136/bmjopen-2024-089558.
3
Utilizing PRAME Expression and a Meta-Analytic Framework for iSALT to Explore Atypical Late-Onset Nevi of the Elderly and Their Relationship With Lentiginous and Nested Nevoid Melanomas.利用PRAME表达和iSALT的荟萃分析框架来探索老年人非典型迟发性痣及其与雀斑样和巢状痣样黑色素瘤的关系。
Am J Dermatopathol. 2024 Dec 1;46(12):825-832. doi: 10.1097/DAD.0000000000002847. Epub 2024 Oct 15.
4
A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management.皮肤科医生使用诊断性基因表达谱检测指导患者管理的临床影响研究。
Melanoma Manag. 2024 May 9;11(1):MMT68. doi: 10.2217/mmt-2023-0002. eCollection 2024.
5
The effects of the COVID-19 pandemic on the diagnosis and prognosis of melanoma 2 years after the pandemic in two Romanian counties.新冠疫情对罗马尼亚两个县疫情爆发两年后黑色素瘤诊断和预后的影响。
Front Med (Lausanne). 2024 Jan 23;11:1328488. doi: 10.3389/fmed.2024.1328488. eCollection 2024.
6
Overdiagnosis in Melanoma Screening: Is It a Real Problem?黑色素瘤筛查中的过度诊断：这是一个实际问题吗？
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023247. doi: 10.5826/dpc.1304a247.
7
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.《黑素细胞病理评估工具修订版和黑素细胞病变诊断分类方案等级：共识声明》。
JAMA Netw Open. 2023 Jan 3;6(1):e2250613. doi: 10.1001/jamanetworkopen.2022.50613.
8
Cancer overdiagnosis: a challenge in the era of screening.癌症过度诊断：筛查时代的一项挑战。
J Natl Cancer Cent. 2022 Dec;2(4):235-242. doi: 10.1016/j.jncc.2022.08.005. Epub 2022 Aug 21.
9
Melanoma overdiagnosis: why it matters and what can be done about it.黑色素瘤过度诊断：为什么它很重要以及我们可以为此做些什么。
Br J Dermatol. 2022 Oct;187(4):459-460. doi: 10.1111/bjd.21750. Epub 2022 Aug 5.
10
Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital.多发性原发性黑色素瘤：三级医疗中心的回顾性研究
J Clin Med. 2022 Apr 22;11(9):2355. doi: 10.3390/jcm11092355.
本文引用的文献
1
The Rapid Rise in Cutaneous Melanoma Diagnoses.皮肤黑色素瘤诊断数量的迅速上升。
N Engl J Med. 2021 Jan 7;384(1):72-79. doi: 10.1056/NEJMsb2019760.
2
Estimating the magnitude of cancer overdiagnosis in Australia.估算澳大利亚癌症过度诊断的程度。
Med J Aust. 2020 Mar;212(4):163-168. doi: 10.5694/mja2.50455. Epub 2019 Dec 19.
3
Should we rename low risk cancers?我们应该重新命名低风险癌症吗？
BMJ. 2019 Jan 23;364:k4699. doi: 10.1136/bmj.k4699.
4
Renaming low risk conditions labelled as cancer.重新命名被标记为癌症的低风险病症。
BMJ. 2018 Aug 12;362:k3322. doi: 10.1136/bmj.k3322.
5
Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.病理学家对侵袭性黑色素瘤和黑素细胞增殖的诊断：观察者准确性和可重复性研究。
BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813.
6
Fear of new or recurrent melanoma after treatment for localised melanoma.局部黑色素瘤治疗后对新发或复发性黑色素瘤的恐惧。
Psychooncology. 2017 Nov;26(11):1784-1791. doi: 10.1002/pon.4366. Epub 2017 Feb 2.
7
The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.黑素细胞性增生及黑色素瘤的 MPATH-Dx 报告方案。
J Am Acad Dermatol. 2014 Jan;70(1):131-41. doi: 10.1016/j.jaad.2013.07.027. Epub 2013 Oct 28.
Zotero 插件